Bisphosphonates and Bone Microdamage
Osteoporosis is a significant healthcare issue due to the increasing elderly population. Bisphosphonates are used to treat osteoporosis by reducing the rate of resorption, increasing bone mineral density (BMD) and thereby reducing fracture risk. Long-term bisphosphonate treatment, however, has been...
Main Author: | Caruthers, William A |
---|---|
Format: | Others |
Published: |
UKnowledge
2012
|
Subjects: | |
Online Access: | http://uknowledge.uky.edu/cbme_etds/4 http://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1005&context=cbme_etds |
Similar Items
-
The Effect of Varying Bisphosphonate Treatment on Changes in Bone Microdamage in Osteoporotic Women
by: Pagano, Stefanie L.
Published: (2016) -
Modeling the Long Term Effects of Alendronate on Bone Mass Preservation of the Femur with Articular Surface and Total Hip Replacements
by: Hryce, Trevor J
Published: (2010) -
Modeling Viscoelastic Behavior in Compact Bone through a Distribution of Collagen D-Spacing: A Finite Element Analysis
by: Ha, Christopher
Published: (2015) -
Morphological and histomorphometric evaluation of autogenous bone graft resorption in rabbits treated with alendronate sodium
by: Teo Mario da ROSA, et al. -
Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?
by: Louise Statham, et al.
Published: (2020-05-01)